bisindolylmaleimide i has been researched along with Immunologic Deficiency Syndromes in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glassford, J | 1 |
| Soeiro, I | 1 |
| Skarell, SM | 1 |
| Banerji, L | 1 |
| Holman, M | 1 |
| Klaus, GG | 1 |
| Kadowaki, T | 1 |
| Koyasu, S | 1 |
| Lam, EW | 1 |
1 other study available for bisindolylmaleimide i and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
Topics: Adaptor Proteins, Signal Transducing; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Antibodi | 2003 |